Teva (TEVA -0.4%) announces the launch of generic ACTOplus met in the U.S. The drug is marketed...

|About: Teva Pharmaceutical Industr... (TEVA)|By:, SA News Editor

Teva (TEVA -0.4%) announces the launch of generic ACTOplus met in the U.S. The drug is marketed by Takeda Pharmaceuticals and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. ACTOplus met had annual sales of approximately $413M in the United States through June.